<DOC>
	<DOC>NCT00147589</DOC>
	<brief_summary>To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and about 320 patients will participate.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>616 years old male and female Systolic blood pressure greater than or equal to the 95th percentile for age, gender, and height, measured on at least 3 separate occasions K/DOQI classification of stages of chronic kidney disease equal to or greater than 3 Serum or whole blood potassium &gt; 5.5 mEq/L</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>